Aethlon medical announces fiscal second quarter financial results and provides corporate update

Conference call to be held today at 4:30 p.m. et san diego , nov. 14, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal second quarter ended september 30, 2023 and provided an update on recent developments.
AEMD Ratings Summary
AEMD Quant Ranking